Condition
Junctional Epidermolysis Bullosa clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Junctional Epidermolysis Bullosa clinical trials that are recruiting, at sites in 9 countries (most in United States (2), Japan (1), Taiwan (1)). By phase: Phase 2 (2), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 9Countries
Newest Junctional Epidermolysis Bullosa clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Energy-F703EB Cream for Epidermolysis Bullosa: a skin cream test in adults | Phase 2 | Tainan | Recruiting | Oct 5, 2026 |
| Oleogel-S10 gel for healing skin wounds in Japanese patients with epidermolysis bullosa. | Phase 3 | Fukuoka and 5 other locations | Recruiting | Apr 8, 2025 |
| Topical TCP-25 gel to help heal wounds in epidermolysis bullosa | Phase 2 | Cincinnati, Ohio and 12 other locations | Recruiting | Sep 19, 2024 |
| Using gentamicin to treat junctional epidermolysis bullosa | Phase 1/2 | Los Angeles, California | Recruiting | May 16, 2018 |
All recruiting trials (4)
-
Energy-F703EB Cream for Epidermolysis Bullosa: a skin cream test in adults
This phase 2 study tests ENERGI-F703EB Cream versus a matching vehicle to see if it is safe and helps small EB skin lesions in adults.
-
Oleogel-S10 gel for healing skin wounds in Japanese patients with epidermolysis bullosa.
We will try Oleogel‑S10 gel to see if it closes or shrinks wounds in Japanese children and adults with junctional or dystrophic epidermolysis bullosa.
-
Topical TCP-25 gel to help heal wounds in epidermolysis bullosa
This trial tests whether applying TCP-25 gel to matched skin wounds helps improve healing in children and adults with dystrophic or junctional epidermolysis bullosa.
-
Using gentamicin to treat junctional epidermolysis bullosa
This study is testing if a medication called gentamicin can help improve skin healing and condition in people with a rare skin disorder caused by specific gene mutations.
Related topics
Quick answers
How many Junctional Epidermolysis Bullosa clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (2 trials), Japan (1 trial), Taiwan (1 trial), France (1 trial), Greece (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.